New techniques in MR imaging of brain tumors

Magnetic Resonance Imaging Clinics of North America

Volumn 8, Issue 4, 2000, Pages 691-713

  Pomper, M G ^a   Port, J D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPROSIUM; GADOLINIUM; IRON OXIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SODIUM 23;

BRAIN TUMOR; CANCER SURGERY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; INTRAOPERATIVE CARE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREOPERATIVE CARE;

EID: 0033664629     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Presurgical evaluation of the motor hand area with functional MR imaging in patients with tumors and dysplastic lesions
2. Focal brain lesions: Effect of single-voxel proton MR spectroscopic findings on treatment decisions
3. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis
4. Analysis of cystic intracranial lesions performed with fluid-attenuated inversion recovery MR imaging
5. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings
6. 3D spin-lock imaging of human gliomas
7. 1H MRS of glial brain tumors: Correlation with tissue histology and in vitro MRS
8. The use of diffusion tensor imaging in quantifying the effect of dexamethasone on brain tumours
9. Language dominance determined by whole brain functional MRI in patients with brain lesions
10. Echo planar perfusion imaging with high spatial and temporal resolution: Methodology and clinical aspects
11. The development of in vivo imaging systems to study gene expression
12. Metastatic lesions of the brain: Imaging with magnetization transfer
13. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
14. Primary intracranial tumor imaging: A comparison of magnetic resonance and CT
15. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: Correlation with structural alteration in gliomas of the cerebral hemispheres
16. Functional magnetic resonance imaging: You get what you (barely) see
17. Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings
18. High spatial resolution functional magnetic resonance imaging at very high magnetic field
19. 11C-methyl] thymidine PET
20. Diffusion-weighted MRI postoperative assessment of an epidermoid tumor in the cerebellopontine angle
21. Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses
22. Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy
23. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging
24. EPISTAR MRI: Multislice mapping of cerebral blood flow
25. Echo-planar MR imaging
26. Improved delineation of human brain tumors on MR images using a long-circulating superparamagnetic iron oxide agent
27. Fast fluid-attenuated inversion recovery (FLAIR) MRI in the assessment of intra-axial brain tumors
28. Cerebral gliomas and metastases: Assessment with contrast-enhanced fast fluid-attenuated inversion recovery MR imaging
29. Intraoperafive validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex
30. A T1-weighted rapid three-dimensional gradient-echo technique (MPRAGE) in preoperative MRI of intracranial tumours
31. T1-weighted three-dimensional magnetization transfer MR of the brain: Improved lesion contrast enhancement
32. Antiangiogenic gene therapy
33. Technical solution for an interactive functional MR imaging examination: Application to a physiologic interview and the study of cerebral physiology
34. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
35. 1H MR spectroscopy: Initial results
36. Overview of diffusion imaging
37. Sodium MR imaging of the brain: Initial clinical results
38. Increased 9-aminocampothecin dose requirements in patients on anticonvulsants
39. Phase II study of continuous infusion BCNU and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytomas
40. 1H NMR spectra with increased magnetic field strength
41. 1H spectroscopic imaging, and quantitative histology in human glioma
42. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma
43. Three-dimensional triple-quantum-filtered (23)Na imaging of in vivo human brain
44. The clinical applications of functional MR imaging
45. Contrast-enhanced magnetization transfer imaging: Improvement of brain tumor conspicuity and delineation for radiosurgical target volume definition
46. In vivo NMR imaging of sodium-23 in the human head
47. Comparison of diffusion anisotropy measurements in combination with the FLAIR technique
48. Decreased BOLD functional MR activation of the motor and sensory cortices adjacent to a glioblastoma multiforme: Implications for image-guided neurosurgery
49. 1H MRS, diffusion, and perfusion MRI
50. Treatment of recurrent high-grade astrocytoma: Results of a systematic review of 1415 patients
51. Imaging the pyramidal tract in patients with brain tumors
52. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors
53. Choline in proton MR spectroscopy correlates with MIB-1 proliferation index in gliomas
54. Brain abscess and necrotic or cystic brain tumor: Discrimination with signal intensity on diffusion-weighted MR imaging
55. MR enhancement of brain lesions: Increased contrast dose compared with magnetization transfer
56. Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas
57. Glial neoplasms: Dynamic contrast-enhanced T2(*)-weighted MR imaging
58. Ultrafast FLAIR imaging with single-shot echo-planar technique in evaluation of intracranial lesions
59. Abnormal diffusion-weighted MRI in medulloblastoma: Does it reflect small cell histology?
60. MR diffusion imaging of human intracranial tumors
61. Assessment of functional MR imaging in neurosurgical planning
62. Arterial spin-labeled perfusion MRI of native and treated human brain tumors: Preliminary comparison with dynamic contrast enhanced rCBV and FDG-PET
63. Clinical applications of intracranial perfusion imaging
64. Comparison of fMRI and intraoperative direct cortical stimulation in localization of receptive language areas
65. 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy
66. Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions
67. 1 MRSI
68. Contrast-enhanced magnetization transfer MR of the brain: Importance of precontrast images
69. The importance of precontrast magnetization transfer images
70. 1H MRSI is reliable in directing therapy of suspected relapsing neoplasms
71. Diffusion magnetic resonance imaging: Its principles and applications
72. Clinical application of three-dimensional anisotropy contrast magnetic resonance axonography
73. Imaging of brain tumors after therapy
74. 1H MRSI
75. Detection of brain metastasis: Comparison of turbo-FLAIR imaging, T2-weighted imaging, and double-dose gadolinium-enhanced MR imaging
76. Brain lesions: When should fluid-attenuated inversion-recovery sequences be used in MR evaluation?
77. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors
78. Functional MR imaging correlations with positron emission tomography
79. Magnetization transfer time-of-flight magnetic resonance angiography
80. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
81. Imaging of adult brain tumors
82. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery sequence
83. 1H MR spectroscopy
84. Functional MRI-guided surgery of intracranial tumors
85. Intraoperative MR imaging guidance for intracranial neurosurgery: Experience with the first 200 cases
86. 23Na shift reagent for the in vivo rat kidney
87. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma
88. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow-up of brain tumors
89. Echo-planar FLAIR imaging in evaluation of intracranial lesions
90. In vivo accuracy testing and clinical experience with the ISG viewing wand
91. Contrast agents in functional MR imaging
92. Comparison of static and dynamic MRI techniques for the measurement of regional cerebral blood volume
93. Spin diffusion measurements: Spin-echoes in the presence of a time-dependent field gradient
94. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas
95. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas
96. Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging
97. Oxygen dependence of the transverse relaxation time of water protons in whole blood at high field
98. MR imaging of high-grade cerebral gliomas: Value of diffusion-weighted echo-planar pulse sequences
99. Diffusion-weighted MR imaging of the brain: Value in differentiating between extra axial cysts and epidermoid tumors
100. Echo-planar imaging of intravoxel motion
101. Functional mapping in the human brain using high magnetic fields
102. Expression of voltage-activated chloride currents in acute slices of human gliomas
103. Orientation-independent diffusion imaging without tensor diagonalization: Anisotropy definitions based on physical attributes of the diffusion ellipsoid
104. MR imaging and scintigraphy of gene expression through melanin induction
105. Implantable biodegradable polymers for IUdR radio-sensitization of experimental human malignant glioma
106. Magnetization transfer imaging: Practical aspects and clinical applications
107. Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin-labeling
108. Quantitative CBF mapping on brain tumor patients using multislice perfusion imaging with pulsed arterial spin-labeling
109. MR evaluation of CNS tumors: Dose comparison study with gadopentetate dimeglumine and gadoteridol